The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer
China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selection between gastric cancer patients from the Eastern and Western co...
Saved in:
| Published in | Cancer communications (London, England) Vol. 39; no. 1; pp. 1 - 31 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
18.03.2019
John Wiley & Sons, Inc Wiley |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2523-3548 2523-3548 |
| DOI | 10.1186/s40880-019-0349-9 |
Cover
| Abstract | China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selection between gastric cancer patients from the Eastern and Western countries. Non-Chinese guidelines cannot specifically reflect the diagnosis and treatment characteristics for the Chinese gastric cancer patients. The Chinese Society of Clinical Oncology (CSCO) arranged for a panel of senior experts specializing in all sub-specialties of gastric cancer to compile, discuss, and revise the guidelines on the diagnosis and treatment of gastric cancer based on the findings of evidence-based medicine in China and abroad. By referring to the opinions of industry experts, taking into account of regional differences, giving full consideration to the accessibility of diagnosis and treatment resources, these experts have conducted experts’ consensus judgement on relevant evidence and made various grades of recommendations for the clinical diagnosis and treatment of gastric cancer to reflect the value of cancer treatment and meeting health economic indexes. This guideline uses tables and is complemented by explanatory and descriptive notes covering the diagnosis, comprehensive treatment, and follow-up visits for gastric cancer. |
|---|---|
| AbstractList | China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selection between gastric cancer patients from the Eastern and Western countries. Non-Chinese guidelines cannot specifically reflect the diagnosis and treatment characteristics for the Chinese gastric cancer patients. The Chinese Society of Clinical Oncology (CSCO) arranged for a panel of senior experts specializing in all sub-specialties of gastric cancer to compile, discuss, and revise the guidelines on the diagnosis and treatment of gastric cancer based on the findings of evidence-based medicine in China and abroad. By referring to the opinions of industry experts, taking into account of regional differences, giving full consideration to the accessibility of diagnosis and treatment resources, these experts have conducted experts' consensus judgement on relevant evidence and made various grades of recommendations for the clinical diagnosis and treatment of gastric cancer to reflect the value of cancer treatment and meeting health economic indexes. This guideline uses tables and is complemented by explanatory and descriptive notes covering the diagnosis, comprehensive treatment, and follow-up visits for gastric cancer. Abstract China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selection between gastric cancer patients from the Eastern and Western countries. Non-Chinese guidelines cannot specifically reflect the diagnosis and treatment characteristics for the Chinese gastric cancer patients. The Chinese Society of Clinical Oncology (CSCO) arranged for a panel of senior experts specializing in all sub-specialties of gastric cancer to compile, discuss, and revise the guidelines on the diagnosis and treatment of gastric cancer based on the findings of evidence-based medicine in China and abroad. By referring to the opinions of industry experts, taking into account of regional differences, giving full consideration to the accessibility of diagnosis and treatment resources, these experts have conducted experts’ consensus judgement on relevant evidence and made various grades of recommendations for the clinical diagnosis and treatment of gastric cancer to reflect the value of cancer treatment and meeting health economic indexes. This guideline uses tables and is complemented by explanatory and descriptive notes covering the diagnosis, comprehensive treatment, and follow-up visits for gastric cancer. China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selection between gastric cancer patients from the Eastern and Western countries. Non-Chinese guidelines cannot specifically reflect the diagnosis and treatment characteristics for the Chinese gastric cancer patients. The Chinese Society of Clinical Oncology (CSCO) arranged for a panel of senior experts specializing in all sub-specialties of gastric cancer to compile, discuss, and revise the guidelines on the diagnosis and treatment of gastric cancer based on the findings of evidence-based medicine in China and abroad. By referring to the opinions of industry experts, taking into account of regional differences, giving full consideration to the accessibility of diagnosis and treatment resources, these experts have conducted experts' consensus judgement on relevant evidence and made various grades of recommendations for the clinical diagnosis and treatment of gastric cancer to reflect the value of cancer treatment and meeting health economic indexes. This guideline uses tables and is complemented by explanatory and descriptive notes covering the diagnosis, comprehensive treatment, and follow-up visits for gastric cancer.China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selection between gastric cancer patients from the Eastern and Western countries. Non-Chinese guidelines cannot specifically reflect the diagnosis and treatment characteristics for the Chinese gastric cancer patients. The Chinese Society of Clinical Oncology (CSCO) arranged for a panel of senior experts specializing in all sub-specialties of gastric cancer to compile, discuss, and revise the guidelines on the diagnosis and treatment of gastric cancer based on the findings of evidence-based medicine in China and abroad. By referring to the opinions of industry experts, taking into account of regional differences, giving full consideration to the accessibility of diagnosis and treatment resources, these experts have conducted experts' consensus judgement on relevant evidence and made various grades of recommendations for the clinical diagnosis and treatment of gastric cancer to reflect the value of cancer treatment and meeting health economic indexes. This guideline uses tables and is complemented by explanatory and descriptive notes covering the diagnosis, comprehensive treatment, and follow-up visits for gastric cancer. |
| Author | Yuan, Xiang-Lin Li, Guo-Xin Liu, Hao Tang, Lei Zhou, Zhi-Wei Zhang, Yu-Jing Wang, Xin Xu, Rui-Hua Li, Yuan-Fang Guan, Wen-Long Shen, Lin Ji, Jia-Fu Wu, Qi Zhang, Xiao-Tian Liu, Tian-Shu Xin, Yan Yu, Shan Xu, Hui-Mian Jin, Jing Liang, Han Li, Jin Wang, Feng-Hua |
| Author_xml | – sequence: 1 givenname: Feng-Hua surname: Wang fullname: Wang, Feng-Hua organization: Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine – sequence: 2 givenname: Lin surname: Shen fullname: Shen, Lin organization: Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute – sequence: 3 givenname: Jin surname: Li fullname: Li, Jin organization: Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine – sequence: 4 givenname: Zhi-Wei surname: Zhou fullname: Zhou, Zhi-Wei organization: Department of Gastric Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine – sequence: 5 givenname: Han surname: Liang fullname: Liang, Han organization: Department of Gastric Cancer, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center of Cancer, Tianjin’s Clinical Research Cancer for Cancer, Key Laboratory of Cancer Prevention and Therapy – sequence: 6 givenname: Xiao-Tian surname: Zhang fullname: Zhang, Xiao-Tian organization: Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute – sequence: 7 givenname: Lei surname: Tang fullname: Tang, Lei organization: Medical Imaging Department, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute – sequence: 8 givenname: Yan surname: Xin fullname: Xin, Yan organization: Pathology Laboratory of Gastrointestinal Tumor, The First Hospital of China Medical University – sequence: 9 givenname: Jing surname: Jin fullname: Jin, Jing organization: Department of Radiation Oncology, National Cancer Center, China and Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College – sequence: 10 givenname: Yu-Jing surname: Zhang fullname: Zhang, Yu-Jing organization: Department of Radiotherapy, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine – sequence: 11 givenname: Xiang-Lin surname: Yuan fullname: Yuan, Xiang-Lin organization: Department of Medical Oncology, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology – sequence: 12 givenname: Tian-Shu surname: Liu fullname: Liu, Tian-Shu organization: Department of Medical Oncology, Zhongshan Hospital Affiliated to Fudan University – sequence: 13 givenname: Guo-Xin surname: Li fullname: Li, Guo-Xin organization: Department of General Surgery, Nanfang Hospital Affiliated to Southern Medical University – sequence: 14 givenname: Qi surname: Wu fullname: Wu, Qi organization: Department of Endoscopy Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute – sequence: 15 givenname: Hui-Mian surname: Xu fullname: Xu, Hui-Mian organization: Department of Surgical Oncology, The First Hospital of China Medical University – sequence: 16 givenname: Jia-Fu surname: Ji fullname: Ji, Jia-Fu organization: Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute – sequence: 17 givenname: Yuan-Fang surname: Li fullname: Li, Yuan-Fang organization: Department of Gastric Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine – sequence: 18 givenname: Xin surname: Wang fullname: Wang, Xin organization: Department of Radiation Oncology, National Cancer Center, China and Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College – sequence: 19 givenname: Shan surname: Yu fullname: Yu, Shan organization: Department of Medical Oncology, Zhongshan Hospital Affiliated to Fudan University – sequence: 20 givenname: Hao surname: Liu fullname: Liu, Hao organization: Department of General Surgery, Nanfang Hospital Affiliated to Southern Medical University – sequence: 21 givenname: Wen-Long surname: Guan fullname: Guan, Wen-Long organization: Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine – sequence: 22 givenname: Rui-Hua surname: Xu fullname: Xu, Rui-Hua email: xurh@sysucc.org.cn organization: Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30885279$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkktv1DAUhSNURB_0B7BBltiURcDPJGZRaRRRqFRpFlPWluNHxqOMXexM0fx7nKYtbSVgZev4nM_32ve4OPDBm6J4h-AnhJrqc6KwaWAJES8hobzkr4ojzDApCaPNwZP9YXGa0gbC7Gw4ZeRNcUhylOGaHxW312sD2rXzJhmwCsqZcQ-CBe3gvFNyAEuvwhD6PThrV-3y4xegHk76ndNmmJLAhgjGDNJO9j4kl4D0GozRyHFr_DgBe5nG6BRQ0isT3xavrRySOb1fT4ofF1-v2-_l1fLbZbu4KlWdyyut5FrJztQcNQRayKmtuqayJGsWSVRx2dUKcchMwxViDaSGQo2xghVU0pKT4nLm6iA34ia6rYx7EaQTd0KIvZBxdGowAinGdM2YNVpRDVFXd4jSWkJtSNdZnVnnM-tm122zKTcW5fAM-vzEu7Xow62oKCYNYRlwdg-I4efOpFFsXVJmGKQ3YZcERpyi_JV1na0fXlg3YRd9fiqBMSeIVbSi2fX-aUWPpTx8bzag2aBiSCka-2hBUExTJOYpEnk2xDRFYsrULzLKjXJ0YWrKDf9MLubkLzeY_f-vEu2ixas7NYuTNjHwzEg57nsT_zT-94t_AxYM7mU |
| CitedBy_id | crossref_primary_10_1002_cam4_3518 crossref_primary_10_3389_fonc_2023_1064790 crossref_primary_10_3892_ol_2019_11221 crossref_primary_10_1245_s10434_020_09070_9 crossref_primary_10_1007_s10147_021_02073_w crossref_primary_10_1089_lap_2021_0016 crossref_primary_10_3389_fmed_2022_1072109 crossref_primary_10_1515_med_2022_0593 crossref_primary_10_11569_wcjd_v28_i11_410 crossref_primary_10_2147_OTT_S292388 crossref_primary_10_12677_TCM_2023_127255 crossref_primary_10_1186_s12906_023_04108_3 crossref_primary_10_1016_j_yexcr_2022_113115 crossref_primary_10_12998_wjcc_v10_i6_1834 crossref_primary_10_3389_fmolb_2023_1081762 crossref_primary_10_3390_cancers14143487 crossref_primary_10_1016_j_clinre_2020_10_015 crossref_primary_10_1177_10732748221087059 crossref_primary_10_3748_wjg_v26_i36_5408 crossref_primary_10_2147_PGPM_S283308 crossref_primary_10_1007_s00280_019_03893_4 crossref_primary_10_3389_fonc_2019_01155 crossref_primary_10_1155_2022_6015877 crossref_primary_10_3389_fonc_2021_606764 crossref_primary_10_3390_molecules28114370 crossref_primary_10_1111_anec_12903 crossref_primary_10_3389_fonc_2020_00513 crossref_primary_10_1186_s13244_022_01361_x crossref_primary_10_1001_jamanetworkopen_2021_38432 crossref_primary_10_1038_s41598_022_14717_6 crossref_primary_10_1186_s12885_024_12771_z crossref_primary_10_1186_s12951_022_01613_4 crossref_primary_10_3389_fonc_2020_614785 crossref_primary_10_3390_livers3010011 crossref_primary_10_1002_cam4_5277 crossref_primary_10_1002_jso_27110 crossref_primary_10_1007_s12094_020_02468_7 crossref_primary_10_1186_s12920_022_01367_w crossref_primary_10_1186_s40659_020_00307_1 crossref_primary_10_1620_tjem_2023_J009 crossref_primary_10_3389_fonc_2021_669575 crossref_primary_10_2147_IJN_S289310 crossref_primary_10_2147_OTT_S226300 crossref_primary_10_1186_s12885_020_07764_7 crossref_primary_10_3389_fonc_2022_905922 crossref_primary_10_1016_j_ebiom_2020_103023 crossref_primary_10_1097_MD_0000000000020727 crossref_primary_10_2147_CMAR_S304093 crossref_primary_10_1002_ijc_32490 crossref_primary_10_1155_2022_2286040 crossref_primary_10_2147_OTT_S233086 crossref_primary_10_7717_peerj_14115 crossref_primary_10_3389_fonc_2021_607640 crossref_primary_10_3389_fgene_2022_959170 crossref_primary_10_1016_j_ejso_2020_06_021 crossref_primary_10_1111_jcmm_17522 crossref_primary_10_3389_fonc_2021_723753 crossref_primary_10_1177_15330338221080939 crossref_primary_10_3389_fonc_2023_1118820 crossref_primary_10_3390_cancers14112758 crossref_primary_10_1111_cas_15581 crossref_primary_10_1089_lap_2020_0743 crossref_primary_10_1186_s12876_023_02737_z crossref_primary_10_3389_fgene_2022_881948 crossref_primary_10_1245_s10434_024_15508_1 crossref_primary_10_1007_s10620_020_06705_5 crossref_primary_10_1016_j_heliyon_2023_e14669 crossref_primary_10_3389_fonc_2022_1042314 crossref_primary_10_1039_D1BM01809D crossref_primary_10_1186_s12885_021_07904_7 crossref_primary_10_1001_jama_2023_19918 crossref_primary_10_1002_adma_202007978 crossref_primary_10_11569_wcjd_v30_i5_235 crossref_primary_10_2174_1871520620666200918100422 crossref_primary_10_1080_17474124_2021_1845140 crossref_primary_10_4251_wjgo_v13_i12_2161 crossref_primary_10_1155_2020_3075837 crossref_primary_10_1186_s12876_022_02510_8 crossref_primary_10_3390_medicina58121802 crossref_primary_10_3346_jkms_2021_36_e88 crossref_primary_10_3389_fonc_2022_934958 crossref_primary_10_61186_ijbc_15_4_272 crossref_primary_10_1093_gastro_goab050 crossref_primary_10_7555_JBR_35_20210034 crossref_primary_10_3389_fonc_2021_709617 crossref_primary_10_1002_adhm_202203029 crossref_primary_10_3390_curroncol30010067 crossref_primary_10_4240_wjgs_v15_i12_2855 crossref_primary_10_1016_j_suronc_2020_06_008 crossref_primary_10_2147_CMAR_S326874 crossref_primary_10_1080_08941939_2022_2150337 crossref_primary_10_1055_s_0041_1725071 crossref_primary_10_3389_fsurg_2023_1097927 crossref_primary_10_18632_aging_104000 crossref_primary_10_3389_fonc_2022_911168 crossref_primary_10_1186_s12885_022_10479_6 crossref_primary_10_3389_fphar_2022_845261 crossref_primary_10_1007_s00464_023_10052_7 crossref_primary_10_3390_cancers12082105 crossref_primary_10_1111_his_14244 crossref_primary_10_1002_deo2_97 crossref_primary_10_3348_kjr_2019_0822 crossref_primary_10_3389_fimmu_2022_973085 crossref_primary_10_1002_jcla_24069 crossref_primary_10_1001_jamanetworkopen_2021_21143 crossref_primary_10_1002_slct_202204993 crossref_primary_10_3389_fonc_2021_718556 crossref_primary_10_3389_fsurg_2022_917352 crossref_primary_10_30944_20117582_860 crossref_primary_10_1186_s12943_020_01274_7 crossref_primary_10_1093_ajcn_nqac273 crossref_primary_10_3389_fonc_2019_00696 crossref_primary_10_3389_fonc_2021_699625 crossref_primary_10_1016_j_asjsur_2022_02_023 crossref_primary_10_1093_annonc_mdz197 crossref_primary_10_1186_s12920_022_01299_5 crossref_primary_10_1016_j_prp_2019_152757 crossref_primary_10_1155_2021_6539702 crossref_primary_10_2147_CMAR_S271879 crossref_primary_10_3892_etm_2021_9640 crossref_primary_10_2147_CMAR_S285361 crossref_primary_10_1016_S1470_2045_21_00297_7 crossref_primary_10_3892_ol_2019_10842 crossref_primary_10_1007_s13246_022_01170_y crossref_primary_10_1016_j_suronc_2021_101699 crossref_primary_10_3390_cancers12082125 crossref_primary_10_1002_cac2_12214 crossref_primary_10_1177_10732748221143389 crossref_primary_10_1155_2022_9747880 crossref_primary_10_3389_fonc_2021_627947 crossref_primary_10_1177_1758835920904803 crossref_primary_10_1186_s12957_020_02066_5 crossref_primary_10_1590_0102_672020190001e1514 crossref_primary_10_4236_jcc_2022_1011007 crossref_primary_10_1007_s00262_022_03160_1 crossref_primary_10_3389_fonc_2021_712432 crossref_primary_10_1155_2022_6084732 crossref_primary_10_1186_s12957_021_02218_1 crossref_primary_10_3389_fimmu_2021_651033 crossref_primary_10_4240_wjgs_v16_i12_3764 crossref_primary_10_4236_ojpathology_2022_123010 crossref_primary_10_3389_fonc_2022_927781 crossref_primary_10_1080_15384101_2021_1987676 crossref_primary_10_3390_antiox12050988 crossref_primary_10_1245_s10434_021_11050_6 crossref_primary_10_1186_s12935_021_01956_2 crossref_primary_10_3892_ol_2022_13567 crossref_primary_10_1080_14728214_2021_2010705 crossref_primary_10_1136_bmjopen_2021_057929 crossref_primary_10_15446_revfacmed_v71n3_105765 crossref_primary_10_1155_2024_6217134 crossref_primary_10_12998_wjcc_v9_i29_8718 crossref_primary_10_1186_s12885_021_09062_2 crossref_primary_10_32604_Oncologie_2021_014772 crossref_primary_10_2147_CMAR_S270387 crossref_primary_10_2147_PPA_S286860 crossref_primary_10_1007_s00261_020_02802_1 crossref_primary_10_1007_s11033_023_08630_y crossref_primary_10_1245_s10434_020_09063_8 crossref_primary_10_2147_OTT_S267915 crossref_primary_10_1002_cac2_12033 crossref_primary_10_1016_j_cmpb_2021_105937 crossref_primary_10_1016_j_acra_2019_10_020 crossref_primary_10_4103_jcrt_jcrt_672_22 crossref_primary_10_1002_mco2_70065 crossref_primary_10_1093_carcin_bgac052 crossref_primary_10_5009_gnl220060 crossref_primary_10_12677_ACM_2021_111014 crossref_primary_10_1016_j_bspc_2022_104319 crossref_primary_10_1002_cac2_12281 crossref_primary_10_1186_s12935_019_1089_2 crossref_primary_10_1016_j_tice_2021_101508 crossref_primary_10_1021_acs_jafc_1c02620 crossref_primary_10_14309_ctg_0000000000000625 crossref_primary_10_3389_pore_2021_580800 crossref_primary_10_1002_mc_23592 crossref_primary_10_1186_s12967_023_04688_1 crossref_primary_10_1109_JBHI_2023_3336247 crossref_primary_10_1186_s12885_021_08717_4 crossref_primary_10_3389_fonc_2024_1425572 crossref_primary_10_1002_ddr_21867 crossref_primary_10_1186_s12967_023_04156_w crossref_primary_10_1002_cncr_34019 crossref_primary_10_3389_fonc_2020_601869 crossref_primary_10_3389_fimmu_2024_1327565 crossref_primary_10_1155_2022_5132691 crossref_primary_10_1080_15384101_2020_1749789 crossref_primary_10_1038_s41420_021_00802_8 crossref_primary_10_1038_s41598_023_35556_z crossref_primary_10_1016_S0140_6736_21_00797_2 crossref_primary_10_1111_1759_7714_13233 crossref_primary_10_3389_fonc_2020_526096 crossref_primary_10_3389_fonc_2021_740111 crossref_primary_10_7759_cureus_55597 crossref_primary_10_1055_s_0040_1716333 crossref_primary_10_1002_cac2_12019 crossref_primary_10_3389_fnut_2022_941975 crossref_primary_10_1016_j_jtho_2020_04_028 crossref_primary_10_1186_s12876_021_01937_9 crossref_primary_10_3389_fonc_2020_00692 crossref_primary_10_1097_CM9_0000000000002185 crossref_primary_10_1016_j_clnu_2023_02_019 crossref_primary_10_3389_fonc_2024_1473798 crossref_primary_10_1001_jamanetworkopen_2022_45836 crossref_primary_10_1155_2022_3960929 crossref_primary_10_3389_fphar_2022_911663 crossref_primary_10_3389_fonc_2021_682456 crossref_primary_10_1080_10799893_2021_1887219 crossref_primary_10_1155_2020_1712723 crossref_primary_10_1002_ijc_34296 crossref_primary_10_3389_fmed_2022_836892 crossref_primary_10_1016_j_radonc_2021_11_003 crossref_primary_10_1002_ctm2_32 crossref_primary_10_1002_jso_26446 crossref_primary_10_3389_fphar_2021_659258 crossref_primary_10_3389_fonc_2021_627556 crossref_primary_10_12998_wjcc_v9_i14_3350 crossref_primary_10_11569_wcjd_v32_i6_430 crossref_primary_10_1080_00914037_2021_1960340 crossref_primary_10_12677_ACM_2022_125583 crossref_primary_10_3389_fsurg_2021_723065 crossref_primary_10_1186_s12885_019_6294_9 crossref_primary_10_3389_fonc_2020_539030 crossref_primary_10_62347_JJVS1398 crossref_primary_10_4251_wjgo_v12_i1_37 crossref_primary_10_1177_1758835920937434 crossref_primary_10_3389_fonc_2022_850242 crossref_primary_10_1007_s00261_021_03049_0 crossref_primary_10_1245_s10434_022_12108_9 crossref_primary_10_3389_fonc_2021_650562 crossref_primary_10_2147_CMAR_S275621 crossref_primary_10_4251_wjgo_v16_i6_2610 crossref_primary_10_1080_21645515_2022_2121109 crossref_primary_10_1245_s10434_021_10087_x crossref_primary_10_2217_fon_2021_1315 crossref_primary_10_1007_s00464_021_08337_w crossref_primary_10_1186_s12967_022_03650_x crossref_primary_10_1155_2022_3308801 crossref_primary_10_1186_s13578_021_00678_2 crossref_primary_10_1111_jcmm_16861 crossref_primary_10_4240_wjgs_v15_i4_578 crossref_primary_10_3389_fonc_2021_698811 crossref_primary_10_1007_s00253_021_11358_z crossref_primary_10_3389_fonc_2021_777760 crossref_primary_10_1016_j_biopha_2021_112222 crossref_primary_10_1007_s11684_021_0902_1 crossref_primary_10_3389_fonc_2019_01265 crossref_primary_10_3892_etm_2022_11562 crossref_primary_10_1177_15347354211058464 crossref_primary_10_2147_CMAR_S479025 crossref_primary_10_1155_2022_7850658 crossref_primary_10_1002_ctm2_708 crossref_primary_10_1093_gastro_goac080 crossref_primary_10_1007_s00432_020_03268_w crossref_primary_10_1111_1759_7714_13690 crossref_primary_10_1371_journal_pone_0288111 crossref_primary_10_1177_11795549221142095 crossref_primary_10_1016_j_lanwpc_2024_101031 crossref_primary_10_1158_1541_7786_MCR_20_0180 crossref_primary_10_18632_aging_204520 crossref_primary_10_1038_s41598_019_55641_6 crossref_primary_10_1177_15330338241236658 crossref_primary_10_1111_1751_2980_12945 crossref_primary_10_1089_gtmb_2020_0270 crossref_primary_10_1186_s10020_022_00491_8 crossref_primary_10_1007_s00432_020_03355_y crossref_primary_10_1177_1758835921988996 crossref_primary_10_1016_j_prmcm_2021_100021 crossref_primary_10_1007_s10147_021_01924_w crossref_primary_10_1111_imm_13143 |
| Cites_doi | 10.1200/jco.2013.53.6136 10.1200/JCO.2013.48.8551 10.1007/s10120‐016‐0663‐8 10.1200/JCO.2002.12.032 10.3322/caac.21388 10.1200/JCO.2015.62.6598 10.1371/journal.pone.0080290 10.1016/S0140‐6736(10)61121‐X 10.1200/JCO.2008.17.0506 10.3322/caac.21262 10.1016/j.ijrobp.2017.03.032 10.1093/annonc/mdn717 10.1002/bjs.9484 10.1007/s10120‐011‐0069‐6 10.4143/crt.2003.35.2.109 10.1080/02841860701621233 10.1093/annonc/mdw350 10.1016/j.ejca.2008.10.026 10.1007/s00464‐010‐1493‐0 10.1007/s10120‐015‐0490‐3 10.1200/JCO.2011.36.5908 10.1200/JCO.2006.06.8429 10.1016/j.gie.2011.04.038 10.1007/s11605‐011‐1804‐3 10.1097/SLA.0000000000001814 10.1200/JCO.2007.12.9593 10.1016/S0140‐6736(13)61719‐5 10.1111/ajco.12263 10.1200/JCO.2015.63.5995 10.1007/s10120‐017‐0696‐7 10.1097/SLA.0b013e318167748c 10.1186/1471‐2407‐14‐823 10.1097/SLA.0000000000001542 10.1007/s10147‐015‐0892‐6 10.1016/j.crad.2015.06.083 10.1016/j.meddos.2013.04.007 10.1007/s10120‐012‐0156‐3 10.4143/crt.2013.175 10.1016/S0140‐6736(69)92326‐5 10.1007/s10120‐016‐0622‐4 10.1200/JCO.2006.06.4840 10.1093/jjco/hyp167 10.1002/jso.22149 10.1002/ijc.28559 10.21147/j.issn.1000‐9604.2018.01.01 10.1056/NEJMoa055531 10.1016/S1470‐2045(06)70766‐5 10.1186/s40880‐018‐0344‐6 10.1016/S0140‐6736(11)61873‐4 10.1097/SLA.0b013e3181a3df77 10.1007/s10147‐017‐1128‐8 10.1016/j.critrevonc.2012.08.008 10.1111/1751‐2980.12355 10.1002/14651858.cd009944.pub2 10.1007/s10585‐013‐9606‐5 10.1016/S1470‐2045(08)70035‐4 10.1007/s10120‐015‐0457‐4 10.1016/j.dld.2015.12.012 10.1002/jso.23920 10.1007/s10120‐016‐0604‐6 10.1136/gut.2008.165381 10.1016/S0140‐6736(17)31827‐5 10.1136/gut.2010.228254 10.1016/0360‐3016(83)90383‐8 10.1200/JCO.2007.13.9378 10.1016/j.ejso.2016.03.030 10.1186/1471‐2482‐12‐20 10.6004/jnccn.2016.0137 10.1097/COC.0b013e31828f5cb6 10.18632/oncotarget.10456 10.3892/mco.2015.506 10.1016/j.humpath.2013.12.010 10.1038/sj.bjc.6602572 10.1016/j.ijrobp.2016.06.090 10.1200/JCO.2015.63.7215 10.1007/s00464‐011‐1627‐z 10.1200/JCO.2004.01.015 10.1002/ijc.30383 10.1056/NEJMoa010187 10.1016/j.ejso.2015.03.227 10.1200/JCO.2018.77.8613 10.1200/jco.1995.13.1.8 10.1093/jjco/hym113 10.1002/jmri.24464 10.1186/s12885‐015‐1529‐x 10.1200/JCO.2005.05.0245 10.1007/s10120‐011‐0066‐9 10.1007/s00464‐015‐4534‐x 10.1016/j.ijrobp.2011.08.036 10.1007/s10120‐016‐0684‐3 10.1038/bjc.2016.126 10.1016/S1470‐2045(14)70420‐6 10.1245/s10434‐013‐3397‐4 10.1007/s10120‐016‐0601‐9 10.1001/jamaoncol.2016.6762 10.1093/annonc/mdt232 10.1097/01.sla.0000151892.35922.f2 10.1007/s13277‐013‐1574‐5 10.1080/02656736.2017.1306120 10.1056/NEJMoa0707035 10.1016/j.gie.2007.04.013 10.1002/cncr.25246 10.1007/s00280‐014‐2449‐1 10.1016/j.ejso.2016.03.035 10.1002/jso.23009 10.1245/s10434‐008‐0210‐x 10.1007/s10147‐007‐0706‐6 10.1186/1477‐7819‐10‐274 10.1001/jamaoncol.2018.0013 10.1186/s40880‐018‐0293‐0 10.1186/s40880‐017‐0226‐3 10.1245/s10434‐009‐0706‐z 10.1007/s12094‐016‐1523‐z 10.1007/s11605‐015‐2775‐6 10.3748/wjg.v17.i11.1501 10.1002/1097‐0142(19820501)49:9<1771::AID‐CNCR2820490907>3.0.CO;2‐M 10.1016/j.surg.2013.08.019 10.1016/S1470‐2045(15)00553‐7 10.1200/JCO.2009.25.4706 10.1056/NEJMoa073149 10.1200/jco.2016.34.4_suppl.5 10.1007/s00268‐015‐3326‐8 10.1097/rli.0b013e31823a1495 10.1200/JCO.2011.39.1953 10.1200/JCO.2012.48.5805 10.1016/j.ejso.2017.09.008 10.1007/s10120‐016‐0646‐9 10.1200/JCO.2017.35.15_suppl.4004 10.1016/S1470‐2045(09)70021‐X 10.1007/s10120‐016‐0619‐z 10.1245/s10434‐014‐4018‐6 10.1111/apm.1965.64.1.31 10.1007/s10120‐011‐0041‐5 10.1016/j.ejca.2010.12.021 10.1056/NEJMoa1112088 10.1186/s40880‐017‐0234‐3 10.1007/s10120‐015‐0530‐z 10.1200/JCO.2010.33.0597 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2019 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2019 – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9- K9. KB0 M0R M0S M1P NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s40880-019-0349-9 |
| DatabaseName | Springer Nature OA Free Journals Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database Health & Medical Collection (Alumni) Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 4 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 5 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 6 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2523-3548 |
| EndPage | 31 |
| ExternalDocumentID | oai_doaj_org_article_1c55d755fedc4d01b7b1447a0de3bbfd PMC6423835 30885279 10_1186_s40880_019_0349_9 CAC2S4088001903499 |
| Genre | article Journal Article Practice Guideline |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GroupedDBID | 0R~ 1OC 24P 7RV 7X7 88E 8FI 8FJ ABUWG ACCMX ACXQS ADKYN ADZMN AFKRA ALMA_UNASSIGNED_HOLDINGS ALUQN AMKLP AVUZU AZQEC BENPR BMC C6C CCPQU EBS EJD FYUFA GROUPED_DOAJ HMCUK HYE IAO IHR IHW ITC K9- M0R M1P M~E NAPCQ PHGZM PHGZT PIMPY PJZUB PPXIY PSQYO PUEGO ROL RPM RSV SOJ TEORI UKHRP WIN ACRMQ ADPDF ADUKV ADZOD AHSBF C24 OK1 OVD OVEED AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK DWQXO K9. PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c7279-fa9dcabe791830f094f6b86f3abef1a169ab7c1905e89c15804e40d22c060caf3 |
| IEDL.DBID | C6C |
| ISSN | 2523-3548 |
| IngestDate | Wed Aug 27 01:25:33 EDT 2025 Thu Aug 21 14:03:04 EDT 2025 Fri Sep 05 10:38:38 EDT 2025 Fri Jul 25 06:12:40 EDT 2025 Mon Jul 21 05:36:11 EDT 2025 Thu Apr 24 23:07:22 EDT 2025 Tue Jul 01 02:29:14 EDT 2025 Wed Jan 22 16:35:35 EST 2025 Sat Sep 06 07:29:28 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Chemotherapy Chinese Society of Clinical Oncology (CSCO) Targeted therapy Surgery Immunotherapy Neoadjuvant Adjuvant Diagnosis Radiotherapy Gastric cancer |
| Language | English |
| License | Attribution Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c7279-fa9dcabe791830f094f6b86f3abef1a169ab7c1905e89c15804e40d22c060caf3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Instructional Material/Guideline-3 content type line 23 |
| OpenAccessLink | https://doi.org/10.1186/s40880-019-0349-9 |
| PMID | 30885279 |
| PQID | 2293156464 |
| PQPubID | 2040150 |
| PageCount | 31 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_1c55d755fedc4d01b7b1447a0de3bbfd pubmedcentral_primary_oai_pubmedcentral_nih_gov_6423835 proquest_miscellaneous_2194134977 proquest_journals_2293156464 pubmed_primary_30885279 crossref_primary_10_1186_s40880_019_0349_9 crossref_citationtrail_10_1186_s40880_019_0349_9 wiley_primary_10_1186_s40880_019_0349_9_CAC2S4088001903499 springer_journals_10_1186_s40880_019_0349_9 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-03-18 |
| PublicationDateYYYYMMDD | 2019-03-18 |
| PublicationDate_xml | – month: 03 year: 2019 text: 2019-03-18 day: 18 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: United States – name: Hoboken |
| PublicationTitle | Cancer communications (London, England) |
| PublicationTitleAbbrev | Cancer Commun |
| PublicationTitleAlternate | Cancer Commun (Lond) |
| PublicationYear | 2019 |
| Publisher | BioMed Central John Wiley & Sons, Inc Wiley |
| Publisher_xml | – name: BioMed Central – name: John Wiley & Sons, Inc – name: Wiley |
| References | 2004; 22 2012; 366 2015; 70 2011; 60 2017; 390 2016; 30 1983; 9 2012; 16 2012; 15 2013; 8 2012; 12 2012; 10 2016; 263 2014; 134 2016; 34 2014; 21 2016; 33 2009; 10 2018; 4 2006; 24 2010; 116 2010; 28 2008; 26 2014; 15 2016; 42 2014; 14 2008; 359 2016; 40 2018; 30 2008; 358 2014; 17 2012; 379 2007; 66 2016; 48 2018; 38 2009; 16 2014; 10 2016; 45 2018; 36 2009; 249 2016; 19 2017; 67 2013; 85 2003; 35 2011; 74 2016; 96 2008; 247 2014; 40 2016; 17 2014; 155 2012; 105 2007; 12 2014; 45 2016; 14 2010; 40 2012; 30 2006; 355 2016; 7 1982; 49 2005; 241 2015; 111 2015; 65 2016; 21 2008; 47 2014; 35 2017; 140 2005; 92 2012; 47 2014; 30 2017; 265 2014; 383 2016; 27 2014; 32 2014; 31 2009; 45 2015; 35 1990; 10 2015; 38 2017; 3 2013; 24 2017; 43 2008; 9 2011; 14 2011; 17 2001; 345 2007; 37 1965; 64 2009; 58 2015; 47 2017; 36 1969; 2 2017; 33 2015; 41 2011; 25 2016; 114 2011; 29 2015; 2 2012; 83 2017; 20 2015; 15 2015; 19 2015; 3 2009; 20 1995; 13 2017; 22 2006; 7 2009; 27 2009; 29 2013; 38 2013; 33 2017; 14 2002; 20 2017; 98 2010; 376 2013; 31 2015; 22 2017; 19 2013 2011; 47 2014; 73 2014; 101 e_1_2_12_6_1 e_1_2_12_130_1 e_1_2_12_2_1 e_1_2_12_17_1 e_1_2_12_111_1 e_1_2_12_138_1 Expert Committee on Safety Management of Anti‐neoplastic Drugs of Chinese Society of Clinical Oncology Society of Gastric Cancer of Chinese Anti‐Cancer Association. Society of Pathology of Chinese Anti‐Cancer Association (e_1_2_12_23_1) 2016; 21 e_1_2_12_115_1 e_1_2_12_153_1 e_1_2_12_134_1 Li TCL (e_1_2_12_78_1) 2011; 14 e_1_2_12_108_1 e_1_2_12_66_1 e_1_2_12_43_1 e_1_2_12_85_1 e_1_2_12_24_1 e_1_2_12_47_1 e_1_2_12_89_1 e_1_2_12_62_1 e_1_2_12_81_1 e_1_2_12_100_1 e_1_2_12_123_1 e_1_2_12_28_1 Ajani JA (e_1_2_12_20_1) 2017; 14 e_1_2_12_104_1 e_1_2_12_127_1 e_1_2_12_142_1 Yamamoto M (e_1_2_12_136_1) 2015; 35 e_1_2_12_77_1 e_1_2_12_54_1 e_1_2_12_96_1 e_1_2_12_139_1 e_1_2_12_35_1 e_1_2_12_58_1 Xue WC (e_1_2_12_22_1) 2014; 30 e_1_2_12_12_1 e_1_2_12_73_1 Zhang CH (e_1_2_12_48_1) 2011; 14 e_1_2_12_50_1 e_1_2_12_92_1 e_1_2_12_3_1 e_1_2_12_152_1 e_1_2_12_18_1 e_1_2_12_110_1 e_1_2_12_137_1 e_1_2_12_133_1 e_1_2_12_156_1 Sun Q (e_1_2_12_15_1) 2016; 33 e_1_2_12_44_1 e_1_2_12_63_1 e_1_2_12_86_1 e_1_2_12_107_1 e_1_2_12_25_1 e_1_2_12_67_1 e_1_2_12_40_1 e_1_2_12_82_1 e_1_2_12_141_1 e_1_2_12_122_1 e_1_2_12_29_1 e_1_2_12_149_1 e_1_2_12_126_1 e_1_2_12_103_1 e_1_2_12_145_1 e_1_2_12_32_1 e_1_2_12_55_1 e_1_2_12_74_1 e_1_2_12_97_1 Shen W (e_1_2_12_146_1) 2014; 17 e_1_2_12_36_1 e_1_2_12_59_1 e_1_2_12_13_1 e_1_2_12_7_1 e_1_2_12_51_1 e_1_2_12_70_1 e_1_2_12_93_1 e_1_2_12_4_1 e_1_2_12_151_1 e_1_2_12_19_1 e_1_2_12_38_1 e_1_2_12_132_1 e_1_2_12_113_1 e_1_2_12_155_1 e_1_2_12_41_1 e_1_2_12_87_1 e_1_2_12_106_1 e_1_2_12_129_1 e_1_2_12_64_1 e_1_2_12_45_1 e_1_2_12_26_1 e_1_2_12_68_1 e_1_2_12_83_1 e_1_2_12_60_1 e_1_2_12_140_1 e_1_2_12_121_1 e_1_2_12_148_1 e_1_2_12_102_1 e_1_2_12_125_1 e_1_2_12_144_1 e_1_2_12_52_1 e_1_2_12_98_1 e_1_2_12_118_1 e_1_2_12_33_1 e_1_2_12_75_1 e_1_2_12_56_1 e_1_2_12_37_1 e_1_2_12_79_1 e_1_2_12_14_1 e_1_2_12_90_1 e_1_2_12_8_1 The Expert Group for Gastric Cancer HER2 Test Guidelines (e_1_2_12_31_1) 2016; 45 e_1_2_12_10_1 e_1_2_12_94_1 e_1_2_12_71_1 e_1_2_12_150_1 e_1_2_12_5_1 e_1_2_12_16_1 e_1_2_12_112_1 e_1_2_12_135_1 e_1_2_12_39_1 e_1_2_12_116_1 e_1_2_12_131_1 e_1_2_12_154_1 e_1_2_12_42_1 e_1_2_12_65_1 e_1_2_12_88_1 e_1_2_12_109_1 e_1_2_12_128_1 e_1_2_12_46_1 e_1_2_12_69_1 China Pathological Collaboration Group (e_1_2_12_21_1) 1990; 10 e_1_2_12_80_1 Sasada S (e_1_2_12_53_1) 2009; 29 e_1_2_12_61_1 e_1_2_12_84_1 Expert Committee on Safety Management of Anti‐neoplastic Drugs of Chinese Society of Clinical Oncology (e_1_2_12_114_1) 2015; 2 e_1_2_12_27_1 e_1_2_12_101_1 e_1_2_12_147_1 e_1_2_12_120_1 Ito H (e_1_2_12_49_1) 2013; 33 e_1_2_12_105_1 e_1_2_12_143_1 e_1_2_12_124_1 e_1_2_12_30_1 e_1_2_12_76_1 e_1_2_12_99_1 e_1_2_12_117_1 e_1_2_12_34_1 e_1_2_12_57_1 e_1_2_12_91_1 e_1_2_12_11_1 e_1_2_12_72_1 e_1_2_12_95_1 Shi HP (e_1_2_12_119_1) 2015; 2 e_1_2_12_9_1 |
| References_xml | – volume: 2 start-page: 865 issue: 7626 year: 1969 end-page: 867 article-title: Combined 5‐fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer publication-title: Lancet – volume: 28 start-page: 1547 issue: 9 year: 2010 end-page: 1553 article-title: Multicenter phase III comparison of cisplatin/S‐1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial publication-title: J Clin Oncol. – volume: 38 start-page: 395 issue: 4 year: 2013 end-page: 400 article-title: Single‐arc volumetric‐modulated arc therapy (sVMAT) as adjuvant treatment for gastric cancer: dosimetric comparisons with three‐dimensional conformal radiotherapy (3D‐CRT) and intensity‐modulated radiotherapy (IMRT) publication-title: Med Dosim – volume: 36 start-page: 66 issue: 1 year: 2017 article-title: Estimates of cancer incidence and mortality in China, 2013 publication-title: Chin J Cancer – volume: 14 start-page: 589 issue: 8 year: 2011 end-page: 592 article-title: Analysis of splenic hilar lymph node metastasis in advanced gastric cancer and dissection techniques publication-title: Zhonghua Wei Chang Wai Ke Za Zhi. – volume: 17 start-page: 128 issue: 2 year: 2014 end-page: 132 article-title: Meta‐analysis of prognosis after surgical treatment in gastric cancer patients with liver metastasis publication-title: Zhonghua Wei Chang Wai Ke Za Zhi. – volume: 36 start-page: 61 issue: 1 year: 2017 article-title: Prognostic value of programmed death‐1, programmed death‐ligand 1, programmed death‐ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1‐4N + M0 gastric adenocarcinoma publication-title: Chin J Cancer – volume: 376 start-page: 687 issue: 9742 year: 2010 end-page: 697 article-title: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2‐positive advanced gastric or gastro‐oesophageal junction cancer (ToGA): a phase 3, open‐label, randomised controlled trial publication-title: Lancet – volume: 19 start-page: 1043 issue: 6 year: 2015 end-page: 1051 article-title: Survival benefit of surgical treatment for liver metastases from gastric cancer publication-title: J Gastrointest Surg. – volume: 358 start-page: 36 issue: 1 year: 2008 end-page: 46 article-title: Capecitabine and oxaliplatin for advanced esophagogastric cancer publication-title: N Engl J Med. – volume: 74 start-page: 485 issue: 3 year: 2011 end-page: 493 article-title: Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications publication-title: Gastrointest Endosc. – volume: 265 start-page: 277 issue: 2 year: 2017 end-page: 283 article-title: Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma publication-title: Ann Surg. – article-title: Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin(FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine(ECF/ECX) for resectable gastric and EGJ cancer – volume: 26 start-page: 1435 issue: 9 year: 2008 end-page: 1442 article-title: Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie publication-title: J Clin Oncol. – volume: 35 start-page: 109 issue: 2 year: 2003 end-page: 116 article-title: The prognostic significance of the overexpression of HER‐2/neu in Korean gastric carcinomas and the in vitro effects of anti‐HER‐2/neu antibody on cell growth in the gastric carcinoma cell lines publication-title: Cancer Res Treat. – volume: 105 start-page: 786 issue: 8 year: 2012 end-page: 792 article-title: Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach publication-title: J Surg Oncol. – volume: 19 start-page: 234 issue: 1 year: 2016 end-page: 244 article-title: Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first‐line therapy for advanced or locally recurrent gastric cancer publication-title: Gastric Cancer – volume: 20 start-page: 69 issue: Suppl 1 year: 2017 end-page: 83 article-title: Results of a nation‐wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma publication-title: Gastric Cancer – volume: 20 start-page: 904 issue: 5 year: 2017 end-page: 912 article-title: Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG publication-title: Gastric Cancer – volume: 20 start-page: 699 issue: 4 year: 2017 end-page: 708 article-title: Short‐term surgical outcomes from a phase III study of laparoscopy‐assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer: Japan Clinical Oncology Group Study JCOG0912 publication-title: Gastric Cancer – volume: 241 start-page: 232 issue: 2 year: 2005 end-page: 237 article-title: Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five‐year results of a randomized prospective trial publication-title: Ann Surg. – volume: 114 start-page: 1326 issue: 12 year: 2016 end-page: 1333 article-title: A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer publication-title: Br J Cancer – volume: 12 start-page: 433 issue: 6 year: 2007 end-page: 439 article-title: Billroth 1 versus Roux‐en‐Y reconstructions: a quality‐of‐life survey at 5 years publication-title: Int J Clin Oncol. – volume: 14 start-page: 1286 issue: 10 year: 2016 end-page: 1312 article-title: Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology publication-title: J Natl Compr Canc Netw – volume: 345 start-page: 725 issue: 10 year: 2001 end-page: 730 article-title: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction publication-title: N Engl J Med. – volume: 3 start-page: 699 issue: 3 year: 2015 end-page: 705 article-title: Microsatellite instability and survival in gastric cancer: a systematic review and meta‐analysis publication-title: Mol Clin Oncol. – volume: 263 start-page: 1092 issue: 6 year: 2016 end-page: 1101 article-title: Influence of surgical resection of hepatic metastases from gastric adenocarcinoma on long‐term survival: systematic review and pooled analysis publication-title: Ann Surg. – volume: 21 start-page: 831 issue: 9 year: 2016 end-page: 837 article-title: Chinese expert consensus on the molecular‐targeted therapy for HER‐2‐positive advanced gastric cancer publication-title: Chin Clin Oncol. – volume: 35 start-page: 4369 issue: 5 year: 2014 end-page: 4375 article-title: Efficacy and safety of capecitabine as maintenance treatment after first‐line chemotherapy using oxaliplatin and capecitabine in advanced gastric adenocarcinoma patients: a prospective observation publication-title: Tumour Biol. – volume: 24 start-page: 3953 issue: 24 year: 2006 end-page: 3958 article-title: Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response publication-title: J Clin Oncol. – volume: 12 start-page: 20 year: 2012 article-title: Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases publication-title: BMC Surg. – volume: 47 start-page: 1146 issue: 8 year: 2011 end-page: 1151 article-title: Docetaxel and irinotecan as second‐line therapy for advanced oesophagogastric cancer publication-title: Eur J Cancer – volume: 30 start-page: 268 issue: 3 year: 2012 end-page: 273 article-title: Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial publication-title: J Clin Oncol. – volume: 30 start-page: 2716 issue: 7 year: 2016 end-page: 2722 article-title: Risk factors for under‐diagnosis of gastric intraepithelial neoplasia and early gastric carcinoma in endoscopic forceps biopsy in comparison with endoscopic submucosal dissection in Chinese patients publication-title: Surg Endosc. – volume: 15 start-page: 335 issue: 3 year: 2012 end-page: 337 article-title: Long‐term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study publication-title: Gastric Cancer – volume: 34 start-page: 1448 issue: 13 year: 2016 end-page: 1454 article-title: Randomized, double‐blind, placebo‐controlled phase III trial of apatinib in patients with chemotherapy‐refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction publication-title: J Clin Oncol. – volume: 45 start-page: 228 issue: 2 year: 2009 end-page: 247 article-title: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) publication-title: Eur J Cancer – volume: 33 start-page: 585 issue: 9 year: 2016 end-page: 588 article-title: Pathological standardization of endoscopic mucosal dissection for early gastric cancer and precancerous lesions publication-title: Chin J Dig Endosc. – volume: 359 start-page: 453 issue: 5 year: 2008 end-page: 462 article-title: D2 lymphadenectomy alone or with para‐aortic nodal dissection for gastric cancer publication-title: N Engl J Med. – volume: 22 start-page: 2774 issue: 14 year: 2004 end-page: 2780 article-title: Multi‐institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma publication-title: J Clin Oncol. – volume: 249 start-page: 768 issue: 5 year: 2009 end-page: 775 article-title: A novel subclassification of pT2 gastric cancers according to the depth of muscularis propria invasion: superficial muscularis propria versus deep muscularis propria/subserosa publication-title: Ann Surg. – volume: 47 start-page: 697 issue: 4 year: 2015 end-page: 705 article-title: Comparison of surgery plus chemotherapy and palliative chemotherapy alone for advanced gastric cancer with krukenberg tumor publication-title: Cancer Res Treat. – volume: 105 start-page: 793 issue: 8 year: 2012 end-page: 799 article-title: Neoadjuvant chemotherapy with FOLFOX: improved outcomes in Chinese patients with locally advanced gastric cancer publication-title: J Surg Oncol. – volume: 24 start-page: 2903 issue: 18 year: 2006 end-page: 2909 article-title: Chemotherapy in advanced gastric cancer: a systematic review and meta‐analysis based on aggregate data publication-title: J Clin Oncol. – volume: 20 start-page: 128 issue: Suppl 1 year: 2017 end-page: 134 article-title: Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings publication-title: Gastric Cancer – volume: 17 start-page: 309 issue: 3 year: 2016 end-page: 318 article-title: Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non‐curable factor (REGATTA): a phase 3, randomised controlled trial publication-title: Lancet Oncol. – volume: 134 start-page: 2468 issue: 10 year: 2014 end-page: 2477 article-title: HER2‐positive patients receiving trastuzumab treatment have a comparable prognosis with HER2‐negative advanced gastric cancer patients: a prospective cohort observation publication-title: Int J Cancer – volume: 19 start-page: 197 issue: 2 year: 2017 end-page: 203 article-title: Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis publication-title: Clin Transl Oncol. – volume: 9 start-page: 215 issue: 3 year: 2008 end-page: 221 article-title: S‐1 plus cisplatin versus S‐1 alone for first‐line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial publication-title: Lancet Oncol. – volume: 24 start-page: 2360 issue: 9 year: 2013 end-page: 2364 article-title: HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance publication-title: Ann Oncol. – volume: 21 start-page: 1107 issue: 4 year: 2014 end-page: 1114 article-title: The prognostic significance of an R1 resection in gastric cancer patients treated with adjuvant chemoradiotherapy publication-title: Ann Surg Oncol. – volume: 247 start-page: 759 issue: 5 year: 2008 end-page: 765 article-title: Long‐term benefits of Roux‐en‐Y pouch reconstruction after total gastrectomy: a randomized trial publication-title: Ann Surg. – volume: 379 start-page: 315 issue: 9813 year: 2012 end-page: 321 article-title: Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open‐label, randomised controlled trial publication-title: Lancet – volume: 64 start-page: 31 year: 1965 end-page: 49 article-title: The two histological main types of gastric carcinoma: diffuse and so‐called intestinal‐type carcinoma. An attempt at a histo‐clinical classification publication-title: Acta Pathol Microbiol Scand. – volume: 8 issue: 11 year: 2013 article-title: HER2 status in gastric and gastroesophageal junction cancer assessed by local and central laboratories: Chinese results of the HER‐EAGLE study publication-title: PLoS ONE – volume: 25 start-page: 2666 issue: 8 year: 2011 end-page: 2677 article-title: The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis publication-title: Surg Endosc. – volume: 42 start-page: 1261 issue: 9 year: 2016 end-page: 1267 article-title: Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer publication-title: Syst Rev Meta‐analysis – volume: 33 start-page: 277 issue: 1 year: 2013 end-page: 282 article-title: Prognostic impact of prophylactic splenectomy for upper‐third gastric cancer: a cohort study publication-title: Anticancer Res. – volume: 13 start-page: 8 issue: 1 year: 1995 end-page: 10 article-title: Oligometastases publication-title: J Clin Oncol. – volume: 32 start-page: 627 issue: 7 year: 2014 end-page: 633 article-title: Long‐term results of laparoscopic gastrectomy for gastric cancer: a large‐scale case–control and case‐matched Korean multicenter study publication-title: J Clin Oncol. – volume: 30 start-page: 1 issue: 1 year: 2018 end-page: 12 article-title: Cancer incidence and mortality in China, 2014 publication-title: Chin J Cancer Res. – volume: 16 start-page: 503 issue: 3 year: 2012 end-page: 508 article-title: Differences of the lymphatic distribution and surgical outcomes between remnant gastric cancers and primary proximal gastric cancers publication-title: J Gastrointest Surg. – volume: 27 start-page: 851 issue: 6 year: 2009 end-page: 856 article-title: Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction publication-title: J Clin Oncol. – volume: 9 start-page: 965 issue: 7 year: 1983 end-page: 975 article-title: Combined modality treatment of gastric cancer publication-title: Int J Radiat Oncol Biol Phys – volume: 31 start-page: 25 issue: 1 year: 2014 end-page: 32 article-title: Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer publication-title: Clin Exp Metastasis – volume: 22 start-page: 589 issue: 2 year: 2015 end-page: 596 article-title: Gastric cancer and synchronous hepatic metastases: is it possible to recognize candidates to R0 resection? publication-title: Ann Surg Oncol. – volume: 14 start-page: 1286 year: 2017 end-page: 1312 article-title: Gastric Cancer, Version 5.2017 publication-title: NCCN Clinical Practice Guidelines in Oncology. – volume: 16 start-page: 3227 issue: 12 year: 2009 end-page: 3236 article-title: Induction chemotherapy with S‐1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination publication-title: Ann Surg Oncol. – volume: 29 start-page: 4387 issue: 33 year: 2011 end-page: 4393 article-title: Five‐year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S‐1 versus surgery alone in stage II or III gastric cancer publication-title: J Clin Oncol. – volume: 42 start-page: 1229 issue: 8 year: 2016 end-page: 1235 article-title: Factors influencing survival after hepatectomy for metastases from gastric cancer publication-title: Eur J Surg Oncol. – volume: 48 start-page: 441 issue: 4 year: 2016 end-page: 445 article-title: Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: a retrospective AGEO multicentre study publication-title: Dig Liver Dis. – volume: 111 start-page: 1021 issue: 8 year: 2015 end-page: 1027 article-title: Hepatic resection for gastric cancer liver metastases: a systematic review and meta‐analysis publication-title: J Surg Oncol. – volume: 49 start-page: 1771 issue: 9 year: 1982 end-page: 1777 article-title: A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma publication-title: Cancer – volume: 15 start-page: S3 issue: Suppl 1 year: 2012 end-page: S18 article-title: How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta‐analysis publication-title: Gastric Cancer – year: 2013 – volume: 4 issue: 5 year: 2018 article-title: Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: phase 2 clinical KEYNOTE‐059 trial publication-title: JAMA Oncol. – volume: 2 start-page: 37 year: 2015 end-page: 40 article-title: Guidelines for nutrition therapy in patients with gastric cancer publication-title: J Cancer Metabol Nutr – volume: 40 start-page: 1147 issue: 5 year: 2014 end-page: 1157 article-title: Response to chemotherapy in gastric adenocarcinoma with diffusion‐weighted MRI and (18) F‐FDG‐PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade publication-title: J Magn Reson Imaging – volume: 10 start-page: 191 issue: 2 year: 2009 end-page: 195 article-title: Preoperative treatment and surgery in gastric cancer: friends or foes? publication-title: Lancet Oncol. – volume: 10 start-page: 274 year: 2012 article-title: Prognosis significance of HER‐2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial publication-title: World J Surg Oncol. – volume: 14 start-page: 101 issue: 2 year: 2011 end-page: 112 article-title: Japanese classification of gastric carcinoma: 3rd English edition publication-title: Gastric Cancer – volume: 29 start-page: 3347 issue: 8 year: 2009 end-page: 3351 article-title: Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer publication-title: Anticancer Res. – volume: 65 start-page: 87 issue: 2 year: 2015 end-page: 108 article-title: Global cancer statistics, 2012 publication-title: CA Cancer J Clin. – volume: 20 start-page: 666 issue: 4 year: 2009 end-page: 673 article-title: Capecitabine/cisplatin versus 5‐fluorouracil/cisplatin as first‐line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial publication-title: Ann Oncol. – volume: 15 start-page: 532 year: 2015 article-title: TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG) publication-title: BMC Cancer – volume: 83 start-page: 878 issue: 3 year: 2012 end-page: 886 article-title: Oligometastases treated with stereotactic body radiotherapy: long‐term follow‐up of prospective study publication-title: Int J Radiat Oncol Biol Phys – volume: 366 start-page: 2074 issue: 22 year: 2012 end-page: 2084 article-title: Preoperative chemoradiotherapy for esophageal or junctional cancer publication-title: N Engl J Med. – volume: 43 start-page: 2357 issue: 12 year: 2017 end-page: 2365 article-title: Is it necessary to dissect the posterior lymph nodes along the splenic vessels during total gastrectomy with D2 lymphadenectomy for advanced gastric cancer? publication-title: Eur J Surg Oncol. – volume: 19 start-page: 586 issue: 2 year: 2016 end-page: 596 article-title: A phase II study of perioperative S‐1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival publication-title: Gastric Cancer – volume: 390 start-page: 2461 issue: 10111 year: 2017 end-page: 2471 article-title: Nivolumab in patients with advanced gastric or gastro‐oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO‐4538‐12, ATTRACTION‐2): a randomised, double‐blind, placebo‐controlled, phase 3 trial publication-title: Lancet – volume: 29 start-page: 1715 issue: 13 year: 2011 end-page: 1721 article-title: Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial publication-title: J Clin Oncol. – volume: 31 start-page: 4438 issue: 35 year: 2013 end-page: 4444 article-title: Randomized, open‐label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial publication-title: J Clin Oncol. – volume: 45 start-page: 528 issue: 8 year: 2016 end-page: 532 article-title: Guidelines for HER2 detection of gastric cancer (2016 Edition) publication-title: Chin J Pathol – volume: 14 start-page: 104 issue: 2 year: 2011 end-page: 106 article-title: Efficacy and safety of SOX regimen as neoadjuvant chemotherapy for advanced gastric cancer publication-title: Zhonghua Wei Chang Wai Ke Za Zhi. – volume: 17 start-page: 421 issue: 7 year: 2016 end-page: 432 article-title: Recent advances in proximal gastric carcinoma publication-title: J Dig Dis. – volume: 70 start-page: 1198 issue: 11 year: 2015 end-page: 1204 article-title: Evaluating the response of gastric carcinomas to neoadjuvant chemotherapy using iodine concentration on spectral CT: a comparison with pathological regression publication-title: Clin Radiol – volume: 34 start-page: 5 issue: 4 year: 2016 article-title: A randomized, open‐label, multicenter, adaptive phase 2/3 study of trastuzumab emtansine (T‐DM1) versus a taxane (TAX) in patients (pts) with previously treated HER2‐positive locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma (LA/MGC/GEJC) publication-title: J Clin Oncol. – volume: 30 start-page: 951 issue: 9 year: 2014 end-page: 953 article-title: Expert consensus on selection of related immunohistochemical markers for gastric cancer publication-title: J Clin Exp Pathol – volume: 101 start-page: 653 issue: 6 year: 2014 end-page: 660 article-title: Neoadjuvant chemotherapy with S‐1 and cisplatin followed by D2 gastrectomy with para‐aortic lymph node dissection for gastric cancer with extensive lymph node metastasis publication-title: Br J Surg. – volume: 47 start-page: 421 issue: 3 year: 2008 end-page: 427 article-title: Clinical benefit of palliative radiation therapy in advanced gastric cancer publication-title: Acta Oncol. – volume: 96 start-page: 32 issue: 2 year: 2016 article-title: A randomized phase II trial of neoadjuvant chemotherapy compared with chemoradiation therapy in locally advanced gastroesophageal and gastric adenocarcinoma: preliminary results publication-title: J Radiat Oncol Biol Phys. – volume: 24 start-page: 4991 issue: 31 year: 2006 end-page: 4997 article-title: Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first‐line therapy for advanced gastric cancer: a report of the V325 Study Group publication-title: J Clin Oncol. – volume: 40 start-page: 107 issue: 2 year: 2010 end-page: 111 article-title: Oligometastases and oligo‐recurrence: the new era of cancer therapy publication-title: Jpn J Clin Oncol. – volume: 37 start-page: 836 issue: 11 year: 2007 end-page: 842 article-title: Liver resection for metastatic gastric cancer: experience with 42 patients including eight long‐term survivors publication-title: Jpn J Clin Oncol. – volume: 2 year: 2015 article-title: Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer publication-title: Cochrane Database Syst Rev. – volume: 2 start-page: 841 issue: 9 year: 2015 end-page: 847 article-title: Expert consensus on clinical application of apatinib in treatment of gastric Cancer publication-title: Chin Clin Oncol. – volume: 38 start-page: 72 issue: 1 year: 2018 article-title: Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2‐positive metastatic gastric cancer publication-title: Cancer Commun (Lond) – volume: 17 start-page: 1501 issue: 11 year: 2011 end-page: 1506 article-title: Clinicopathologic significance of HER‐2/neu protein expression and gene amplification in gastric carcinoma publication-title: World J Gastroenterol – volume: 10 start-page: 341 issue: 5,6 year: 1990 end-page: 343 article-title: Pathological analysis of 1477 early gastric cancer cases publication-title: Chin J Digest – volume: 66 start-page: 693 issue: 4 year: 2007 end-page: 700 article-title: EMR for early gastric cancer in Korea: a multicenter retrospective study publication-title: Gastrointest Endosc. – volume: 355 start-page: 11 issue: 1 year: 2006 end-page: 20 article-title: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer publication-title: N Engl J Med. – volume: 116 start-page: 3943 issue: 16 year: 2010 end-page: 3952 article-title: Comparison of intensity‐modulated radiotherapy and 3‐dimensional conformal radiotherapy as adjuvant therapy for gastric cancer publication-title: Cancer – volume: 20 start-page: 322 issue: 2 year: 2017 end-page: 331 article-title: A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S‐1 followed by gastrectomy with D2 plus para‐aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002 publication-title: Gastric Cancer – volume: 45 start-page: 970 issue: 5 year: 2014 end-page: 975 article-title: Matched biopsy and resection specimens of gastric and gastroesophageal adenocarcinoma show high concordance in HER2 status publication-title: Hum Pathol – start-page: 256 year: 2013 – volume: 25 start-page: 1953 issue: 6 year: 2011 end-page: 1961 article-title: Comparison of Billroth I and Billroth II reconstructions after laparoscopy‐assisted distal gastrectomy: a retrospective analysis of large‐scale multicenter results from Korea publication-title: Surg Endosc. – volume: 38 start-page: 130 issue: 2 year: 2015 end-page: 134 article-title: Concurrent involved‐field radiotherapy and XELOX versus XELOX chemotherapy alone in gastric cancer patients with postoperative locoregional recurrence publication-title: Am J Clin Oncol. – volume: 21 start-page: 289 issue: 2 year: 2016 end-page: 294 article-title: The effect of extensive intraoperative peritoneal lavage therapy (EIPL) on stage III B + C and cytology‐positive gastric cancer patients publication-title: Int J Clin Oncol. – volume: 73 start-page: 1155 issue: 6 year: 2014 end-page: 1161 article-title: A phase II trial of Xeloda and oxaliplatin (XELOX) neo‐adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para‐aortic lymph node metastasis publication-title: Cancer Chemother Pharmacol – volume: 47 start-page: 159 issue: 3 year: 2012 end-page: 166 article-title: Diagnostic accuracy and sensitivity of diffusion‐weighted and of gadoxetic acid‐enhanced 3‐T MR imaging alone or in combination in the detection of small liver metastasis (</= 1.5 cm in diameter) publication-title: Invest Radiol. – volume: 15 start-page: 61 issue: 1 year: 2012 end-page: 69 article-title: Phase II trial of combined treatment consisting of preoperative S‐1 plus cisplatin followed by gastrectomy and postoperative S‐1 for stage IV gastric cancer publication-title: Gastric Cancer – volume: 7 start-page: 50656 issue: 31 year: 2016 end-page: 50665 article-title: Efficacy of trastuzumab beyond progression in HER2 positive advanced gastric cancer: a multicenter prospective observational cohort study publication-title: Oncotarget. – volume: 26 start-page: 1086 issue: 7 year: 2008 end-page: 1092 article-title: Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 publication-title: J Clin Oncol. – volume: 20 start-page: 217 issue: 2 year: 2017 end-page: 225 article-title: Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project publication-title: Gastric Cancer – volume: 16 start-page: 42 issue: 1 year: 2009 end-page: 50 article-title: Attempted salvage resection for recurrent gastric or gastroesophageal cancer publication-title: Ann Surg Oncol. – volume: 35 start-page: 4859 issue: 9 year: 2015 end-page: 4863 article-title: Comparison of neoadjuvant chemotherapy to surgery followed by adjuvant chemotherapy in japanese patients with peritoneal lavage cytology positive for gastric carcinoma publication-title: Anticancer Res. – volume: 22 start-page: 887 issue: 5 year: 2017 end-page: 896 article-title: The survival and prognosticators of peritoneal cytology‐positive gastric cancer patients who received upfront gastrectomy and subsequent S‐1 chemotherapy publication-title: Int J Clin Oncol. – volume: 92 start-page: 1976 issue: 11 year: 2005 end-page: 1983 article-title: Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF publication-title: Br J Cancer – volume: 20 start-page: 2844 issue: 12 year: 2002 end-page: 2850 article-title: Oxaliplatin in combination with protracted‐infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer publication-title: J Clin Oncol. – volume: 34 start-page: 443 issue: 5 year: 2016 end-page: 451 article-title: Lapatinib in combination with capecitabine plus oxaliplatin in human epidermal growth factor receptor 2‐positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma: TRIO‐013/LOGiC—a randomized phase III trial publication-title: J Clin Oncol. – volume: 40 start-page: 921 issue: 4 year: 2016 end-page: 928 article-title: Krukenberg tumors of gastric origin: the rationale of surgical resection and perioperative treatments in a multicenter western experience publication-title: World J Surg. – volume: 58 start-page: 331 issue: 3 year: 2009 end-page: 336 article-title: Endoscopic submucosal dissection for early gastric cancer: a large‐scale feasibility study publication-title: Gut – volume: 15 start-page: 1224 issue: 11 year: 2014 end-page: 1235 article-title: Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro‐oesophageal junction adenocarcinoma (RAINBOW): a double‐blind, randomised phase 3 trial publication-title: Lancet Oncol. – volume: 60 start-page: 1449 issue: 11 year: 2011 end-page: 1472 article-title: Guidelines for the management of oesophageal and gastric cancer publication-title: Gut – volume: 34 start-page: 1350 issue: 12 year: 2016 end-page: 1357 article-title: Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer: a randomized controlled trial publication-title: J Clin Oncol. – volume: 20 start-page: 379 issue: 2 year: 2017 end-page: 386 article-title: Surgical resection of hepatic metastases from gastric cancer: outcomes from national series in England publication-title: Gastric Cancer – volume: 36 start-page: 1922 issue: 19 year: 2018 end-page: 1929 article-title: Phase III trial comparing intraperitoneal and intravenous paclitaxel Plus S‐1 versus cisplatin Plus S‐1 in patients with gastric cancer with peritoneal metastasis: PHOENIX‐GC trial publication-title: J Clin Oncol. – volume: 383 start-page: 31 issue: 9911 year: 2014 end-page: 39 article-title: Ramucirumab monotherapy for previously treated advanced gastric or gastro‐oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo‐controlled, phase 3 trial publication-title: Lancet – volume: 7 start-page: 644 issue: 8 year: 2006 end-page: 651 article-title: Left thoracoabdominal approach versus abdominal‐transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial publication-title: Lancet Oncol. – volume: 41 start-page: 779 issue: 6 year: 2015 end-page: 786 article-title: Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? publication-title: Eur J Surg Oncol. – volume: 140 start-page: 188 issue: 1 year: 2017 end-page: 196 article-title: Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane‐ and trastuzumab‐naive patients with HER2‐positive, previously treated, advanced, or recurrent gastric cancer (JFMC45‐1102) publication-title: Int J Cancer – volume: 33 start-page: 830 issue: 7 year: 2017 end-page: 835 article-title: Microwave ablation is effective against liver metastases from gastric adenocarcinoma publication-title: Int J Hyperther – volume: 38 start-page: 23 issue: 1 year: 2018 article-title: A novel nomogram individually predicting disease‐specific survival after D2 gastrectomy for advanced gastric cancer publication-title: Cancer Commun (Lond) – volume: 98 start-page: 1096 issue: 5 year: 2017 end-page: 1105 article-title: Multicenter phase 2 study of peri‐irradiation chemotherapy plus intensity modulated radiation therapy with concurrent weekly docetaxel for inoperable or medically unresectable nonmetastatic gastric cancer publication-title: Int J Radiat Oncol Biol Phys – volume: 67 start-page: 93 issue: 2 year: 2017 end-page: 99 article-title: The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging publication-title: CA Cancer J Clin. – volume: 14 start-page: 823 year: 2014 article-title: Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients publication-title: BMC Cancer – volume: 85 start-page: 350 issue: 3 year: 2013 end-page: 362 article-title: Advanced HER2‐positive gastric cancer: current and future targeted therapies publication-title: Crit Rev Oncol Hematol – volume: 27 start-page: v38 issue: suppl 5 year: 2016 end-page: v49 article-title: Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow‐up publication-title: Ann Oncol. – volume: 155 start-page: 408 issue: 3 year: 2014 end-page: 416 article-title: Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer publication-title: Surgery. – volume: 19 start-page: 968 issue: 3 year: 2016 end-page: 976 article-title: Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302) publication-title: Gastric Cancer – volume: 3 start-page: 1197 issue: 9 year: 2017 end-page: 1203 article-title: Mismatch repair deficiency, microsatellite instability, and survival: an exploratory analysis of the medical research council adjuvant gastric infusional chemotherapy (MAGIC) trial publication-title: JAMA Oncol. – volume: 20 start-page: 1 issue: 1 year: 2017 end-page: 19 article-title: Japanese gastric cancer treatment guidelines 2014 (ver. 4) publication-title: Gastric Cancer – volume: 10 start-page: 297 issue: 4 year: 2014 end-page: 307 article-title: Human epidermal growth factor receptor 2 testing in gastric cancer: recommendations of an Asia‐Pacific task force publication-title: Asia Pac J Clin Oncol. – volume: 32 start-page: 2039 issue: 19 year: 2014 end-page: 2049 article-title: Lapatinib plus paclitaxel versus paclitaxel alone in the second‐line treatment of HER2‐amplified advanced gastric cancer in Asian populations: TyTAN—a randomized, phase III study publication-title: J Clin Oncol. – ident: e_1_2_12_108_1 doi: 10.1200/jco.2013.53.6136 – ident: e_1_2_12_58_1 doi: 10.1200/JCO.2013.48.8551 – ident: e_1_2_12_47_1 doi: 10.1007/s10120‐016‐0663‐8 – ident: e_1_2_12_85_1 doi: 10.1200/JCO.2002.12.032 – ident: e_1_2_12_8_1 doi: 10.3322/caac.21388 – ident: e_1_2_12_109_1 doi: 10.1200/JCO.2015.62.6598 – ident: e_1_2_12_26_1 doi: 10.1371/journal.pone.0080290 – ident: e_1_2_12_24_1 doi: 10.1016/S0140‐6736(10)61121‐X – ident: e_1_2_12_80_1 doi: 10.1200/JCO.2008.17.0506 – ident: e_1_2_12_2_1 doi: 10.3322/caac.21262 – volume: 14 start-page: 589 issue: 8 year: 2011 ident: e_1_2_12_48_1 article-title: Analysis of splenic hilar lymph node metastasis in advanced gastric cancer and dissection techniques publication-title: Zhonghua Wei Chang Wai Ke Za Zhi. – ident: e_1_2_12_90_1 doi: 10.1016/j.ijrobp.2017.03.032 – ident: e_1_2_12_97_1 doi: 10.1093/annonc/mdn717 – ident: e_1_2_12_141_1 doi: 10.1002/bjs.9484 – ident: e_1_2_12_6_1 doi: 10.1007/s10120‐011‐0069‐6 – ident: e_1_2_12_35_1 doi: 10.4143/crt.2003.35.2.109 – ident: e_1_2_12_94_1 doi: 10.1080/02841860701621233 – ident: e_1_2_12_155_1 doi: 10.1093/annonc/mdw350 – ident: e_1_2_12_11_1 doi: 10.1016/j.ejca.2008.10.026 – ident: e_1_2_12_61_1 doi: 10.1007/s00464‐010‐1493‐0 – ident: e_1_2_12_72_1 doi: 10.1007/s10120‐015‐0490‐3 – ident: e_1_2_12_66_1 doi: 10.1200/JCO.2011.36.5908 – ident: e_1_2_12_98_1 doi: 10.1200/JCO.2006.06.8429 – volume: 45 start-page: 528 issue: 8 year: 2016 ident: e_1_2_12_31_1 article-title: Guidelines for HER2 detection of gastric cancer (2016 Edition) publication-title: Chin J Pathol – ident: e_1_2_12_44_1 doi: 10.1016/j.gie.2011.04.038 – ident: e_1_2_12_50_1 doi: 10.1007/s11605‐011‐1804‐3 – ident: e_1_2_12_54_1 doi: 10.1097/SLA.0000000000001814 – ident: e_1_2_12_84_1 doi: 10.1200/JCO.2007.12.9593 – ident: e_1_2_12_111_1 doi: 10.1016/S0140‐6736(13)61719‐5 – ident: e_1_2_12_29_1 doi: 10.1111/ajco.12263 – ident: e_1_2_12_64_1 – ident: e_1_2_12_113_1 doi: 10.1200/JCO.2015.63.5995 – ident: e_1_2_12_150_1 doi: 10.1007/s10120‐017‐0696‐7 – ident: e_1_2_12_62_1 doi: 10.1097/SLA.0b013e318167748c – ident: e_1_2_12_34_1 doi: 10.1186/1471‐2407‐14‐823 – ident: e_1_2_12_126_1 doi: 10.1097/SLA.0000000000001542 – ident: e_1_2_12_137_1 doi: 10.1007/s10147‐015‐0892‐6 – ident: e_1_2_12_13_1 doi: 10.1016/j.crad.2015.06.083 – ident: e_1_2_12_96_1 doi: 10.1016/j.meddos.2013.04.007 – ident: e_1_2_12_133_1 doi: 10.1007/s10120‐012‐0156‐3 – ident: e_1_2_12_130_1 doi: 10.4143/crt.2013.175 – volume: 33 start-page: 277 issue: 1 year: 2013 ident: e_1_2_12_49_1 article-title: Prognostic impact of prophylactic splenectomy for upper‐third gastric cancer: a cohort study publication-title: Anticancer Res. – volume: 2 start-page: 37 year: 2015 ident: e_1_2_12_119_1 article-title: Guidelines for nutrition therapy in patients with gastric cancer publication-title: J Cancer Metabol Nutr – ident: e_1_2_12_91_1 doi: 10.1016/S0140‐6736(69)92326‐5 – volume: 29 start-page: 3347 issue: 8 year: 2009 ident: e_1_2_12_53_1 article-title: Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer publication-title: Anticancer Res. – ident: e_1_2_12_42_1 doi: 10.1007/s10120‐016‐0622‐4 – ident: e_1_2_12_81_1 doi: 10.1200/JCO.2006.06.4840 – ident: e_1_2_12_120_1 doi: 10.1093/jjco/hyp167 – ident: e_1_2_12_52_1 doi: 10.1002/jso.22149 – ident: e_1_2_12_27_1 doi: 10.1002/ijc.28559 – ident: e_1_2_12_4_1 doi: 10.21147/j.issn.1000‐9604.2018.01.01 – ident: e_1_2_12_70_1 doi: 10.1056/NEJMoa055531 – ident: e_1_2_12_45_1 doi: 10.1016/S1470‐2045(06)70766‐5 – ident: e_1_2_12_28_1 doi: 10.1186/s40880‐018‐0344‐6 – ident: e_1_2_12_65_1 doi: 10.1016/S0140‐6736(11)61873‐4 – ident: e_1_2_12_19_1 doi: 10.1097/SLA.0b013e3181a3df77 – ident: e_1_2_12_134_1 doi: 10.1007/s10147‐017‐1128‐8 – ident: e_1_2_12_36_1 doi: 10.1016/j.critrevonc.2012.08.008 – ident: e_1_2_12_17_1 doi: 10.1111/1751‐2980.12355 – ident: e_1_2_12_9_1 doi: 10.1002/14651858.cd009944.pub2 – ident: e_1_2_12_128_1 doi: 10.1007/s10585‐013‐9606‐5 – ident: e_1_2_12_100_1 doi: 10.1016/S1470‐2045(08)70035‐4 – ident: e_1_2_12_99_1 doi: 10.1007/s10120‐015‐0457‐4 – ident: e_1_2_12_154_1 doi: 10.1016/j.dld.2015.12.012 – ident: e_1_2_12_149_1 doi: 10.1002/jso.23920 – ident: e_1_2_12_148_1 doi: 10.1007/s10120‐016‐0604‐6 – ident: e_1_2_12_39_1 doi: 10.1136/gut.2008.165381 – ident: e_1_2_12_115_1 doi: 10.1016/S0140‐6736(17)31827‐5 – ident: e_1_2_12_41_1 – ident: e_1_2_12_7_1 doi: 10.1136/gut.2010.228254 – ident: e_1_2_12_89_1 doi: 10.1016/0360‐3016(83)90383‐8 – ident: e_1_2_12_93_1 doi: 10.1200/JCO.2007.13.9378 – ident: e_1_2_12_152_1 doi: 10.1016/j.ejso.2016.03.030 – volume: 14 start-page: 1286 year: 2017 ident: e_1_2_12_20_1 article-title: Gastric Cancer, Version 5.2017 publication-title: NCCN Clinical Practice Guidelines in Oncology. – ident: e_1_2_12_147_1 doi: 10.1186/1471‐2482‐12‐20 – ident: e_1_2_12_156_1 doi: 10.6004/jnccn.2016.0137 – volume: 17 start-page: 128 issue: 2 year: 2014 ident: e_1_2_12_146_1 article-title: Meta‐analysis of prognosis after surgical treatment in gastric cancer patients with liver metastasis publication-title: Zhonghua Wei Chang Wai Ke Za Zhi. – ident: e_1_2_12_124_1 doi: 10.1097/COC.0b013e31828f5cb6 – ident: e_1_2_12_107_1 doi: 10.18632/oncotarget.10456 – ident: e_1_2_12_37_1 doi: 10.3892/mco.2015.506 – ident: e_1_2_12_30_1 doi: 10.1016/j.humpath.2013.12.010 – ident: e_1_2_12_75_1 doi: 10.1038/sj.bjc.6602572 – volume: 14 start-page: 104 issue: 2 year: 2011 ident: e_1_2_12_78_1 article-title: Efficacy and safety of SOX regimen as neoadjuvant chemotherapy for advanced gastric cancer publication-title: Zhonghua Wei Chang Wai Ke Za Zhi. – ident: e_1_2_12_86_1 doi: 10.1016/j.ijrobp.2016.06.090 – ident: e_1_2_12_60_1 doi: 10.1200/JCO.2015.63.7215 – ident: e_1_2_12_43_1 doi: 10.1007/s00464‐011‐1627‐z – ident: e_1_2_12_87_1 doi: 10.1200/JCO.2004.01.015 – ident: e_1_2_12_106_1 doi: 10.1002/ijc.30383 – ident: e_1_2_12_68_1 doi: 10.1056/NEJMoa010187 – ident: e_1_2_12_46_1 doi: 10.1016/j.ejso.2015.03.227 – ident: e_1_2_12_104_1 doi: 10.1200/JCO.2018.77.8613 – ident: e_1_2_12_122_1 doi: 10.1200/jco.1995.13.1.8 – ident: e_1_2_12_145_1 doi: 10.1093/jjco/hym113 – ident: e_1_2_12_12_1 doi: 10.1002/jmri.24464 – ident: e_1_2_12_82_1 doi: 10.1186/s12885‐015‐1529‐x – ident: e_1_2_12_92_1 doi: 10.1200/JCO.2005.05.0245 – ident: e_1_2_12_140_1 doi: 10.1007/s10120‐011‐0066‐9 – ident: e_1_2_12_14_1 doi: 10.1007/s00464‐015‐4534‐x – ident: e_1_2_12_121_1 doi: 10.1016/j.ijrobp.2011.08.036 – ident: e_1_2_12_138_1 doi: 10.1007/s10120‐016‐0684‐3 – ident: e_1_2_12_73_1 doi: 10.1038/bjc.2016.126 – ident: e_1_2_12_112_1 doi: 10.1016/S1470‐2045(14)70420‐6 – volume: 33 start-page: 585 issue: 9 year: 2016 ident: e_1_2_12_15_1 article-title: Pathological standardization of endoscopic mucosal dissection for early gastric cancer and precancerous lesions publication-title: Chin J Dig Endosc. – volume: 35 start-page: 4859 issue: 9 year: 2015 ident: e_1_2_12_136_1 article-title: Comparison of neoadjuvant chemotherapy to surgery followed by adjuvant chemotherapy in japanese patients with peritoneal lavage cytology positive for gastric carcinoma publication-title: Anticancer Res. – ident: e_1_2_12_69_1 doi: 10.1245/s10434‐013‐3397‐4 – ident: e_1_2_12_16_1 doi: 10.1007/s10120‐016‐0601‐9 – ident: e_1_2_12_38_1 doi: 10.1001/jamaoncol.2016.6762 – ident: e_1_2_12_25_1 doi: 10.1093/annonc/mdt232 – ident: e_1_2_12_59_1 doi: 10.1097/01.sla.0000151892.35922.f2 – ident: e_1_2_12_102_1 doi: 10.1007/s13277‐013‐1574‐5 – ident: e_1_2_12_127_1 doi: 10.1080/02656736.2017.1306120 – volume: 10 start-page: 341 issue: 5 year: 1990 ident: e_1_2_12_21_1 article-title: Pathological analysis of 1477 early gastric cancer cases publication-title: Chin J Digest – ident: e_1_2_12_56_1 doi: 10.1056/NEJMoa0707035 – ident: e_1_2_12_40_1 doi: 10.1016/j.gie.2007.04.013 – volume: 30 start-page: 951 issue: 9 year: 2014 ident: e_1_2_12_22_1 article-title: Expert consensus on selection of related immunohistochemical markers for gastric cancer publication-title: J Clin Exp Pathol – ident: e_1_2_12_95_1 doi: 10.1002/cncr.25246 – ident: e_1_2_12_143_1 doi: 10.1007/s00280‐014‐2449‐1 – ident: e_1_2_12_139_1 doi: 10.1016/j.ejso.2016.03.035 – ident: e_1_2_12_77_1 doi: 10.1002/jso.23009 – ident: e_1_2_12_123_1 doi: 10.1245/s10434‐008‐0210‐x – ident: e_1_2_12_63_1 doi: 10.1007/s10147‐007‐0706‐6 – ident: e_1_2_12_33_1 doi: 10.1186/1477‐7819‐10‐274 – ident: e_1_2_12_116_1 doi: 10.1001/jamaoncol.2018.0013 – ident: e_1_2_12_3_1 doi: 10.1186/s40880‐018‐0293‐0 – ident: e_1_2_12_118_1 doi: 10.1186/s40880‐017‐0226‐3 – volume: 2 start-page: 841 issue: 9 year: 2015 ident: e_1_2_12_114_1 article-title: Expert consensus on clinical application of apatinib in treatment of gastric Cancer publication-title: Chin Clin Oncol. – ident: e_1_2_12_135_1 doi: 10.1245/s10434‐009‐0706‐z – ident: e_1_2_12_153_1 doi: 10.1007/s12094‐016‐1523‐z – ident: e_1_2_12_125_1 doi: 10.1007/s11605‐015‐2775‐6 – ident: e_1_2_12_32_1 doi: 10.3748/wjg.v17.i11.1501 – ident: e_1_2_12_88_1 doi: 10.1002/1097‐0142(19820501)49:9<1771::AID‐CNCR2820490907>3.0.CO;2‐M – ident: e_1_2_12_55_1 doi: 10.1016/j.surg.2013.08.019 – ident: e_1_2_12_144_1 doi: 10.1016/S1470‐2045(15)00553‐7 – ident: e_1_2_12_101_1 doi: 10.1200/JCO.2009.25.4706 – ident: e_1_2_12_76_1 doi: 10.1056/NEJMoa073149 – ident: e_1_2_12_110_1 doi: 10.1200/jco.2016.34.4_suppl.5 – volume: 21 start-page: 831 issue: 9 year: 2016 ident: e_1_2_12_23_1 article-title: Chinese expert consensus on the molecular‐targeted therapy for HER‐2‐positive advanced gastric cancer publication-title: Chin Clin Oncol. – ident: e_1_2_12_131_1 doi: 10.1007/s00268‐015‐3326‐8 – ident: e_1_2_12_10_1 doi: 10.1097/rli.0b013e31823a1495 – ident: e_1_2_12_67_1 doi: 10.1200/JCO.2011.39.1953 – ident: e_1_2_12_105_1 doi: 10.1200/JCO.2012.48.5805 – ident: e_1_2_12_51_1 doi: 10.1016/j.ejso.2017.09.008 – ident: e_1_2_12_57_1 doi: 10.1007/s10120‐016‐0646‐9 – ident: e_1_2_12_79_1 doi: 10.1200/JCO.2017.35.15_suppl.4004 – ident: e_1_2_12_71_1 doi: 10.1016/S1470‐2045(09)70021‐X – ident: e_1_2_12_142_1 doi: 10.1007/s10120‐016‐0619‐z – ident: e_1_2_12_151_1 doi: 10.1245/s10434‐014‐4018‐6 – ident: e_1_2_12_18_1 doi: 10.1111/apm.1965.64.1.31 – ident: e_1_2_12_132_1 doi: 10.1007/s10120‐011‐0041‐5 – ident: e_1_2_12_103_1 doi: 10.1016/j.ejca.2010.12.021 – ident: e_1_2_12_83_1 doi: 10.1056/NEJMoa1112088 – ident: e_1_2_12_5_1 doi: 10.1186/s40880‐017‐0234‐3 – ident: e_1_2_12_117_1 – ident: e_1_2_12_129_1 doi: 10.1007/s10120‐015‐0530‐z – ident: e_1_2_12_74_1 doi: 10.1200/JCO.2010.33.0597 |
| SSID | ssj0001989453 |
| Score | 2.575005 |
| Snippet | China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics, clinicopathological... Abstract China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics,... |
| SourceID | doaj pubmedcentral proquest pubmed crossref wiley springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1 |
| SubjectTerms | Adjuvant Biomedical and Life Sciences Biomedicine Cancer Research Chemotherapy China Chinese Society of Clinical Oncology (CSCO) Clinical practice guidelines Diagnosis Gastric cancer Guideline and Consensus Humans Immunotherapy Medical diagnosis Medical Oncology Neoadjuvant Oncology Radiotherapy Societies, Medical Stomach Neoplasms - diagnosis Stomach Neoplasms - therapy Surgery Targeted therapy |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQiFegVEbiwENW7SS2495KRFUhQQ-lUm-Wn6VSla26XST-fWecbOgK1F642k7izMP-Jp58Q8g7xNkZdlYWQ-Ss9W1mvjOOBYmroUZIgB_0v31Xhyft11N5eqvUF-aEjfTAo-B2RZAyailziqGNXHjtIQbQjsfUeJ8jrr7c8FvBVPm6grzispmOMUWndpctPBZzsAxDShZmNjaiwtf_L5D5d67kfGC6CWfLfnTwmDyagCTdH1_gCXmQhqfkF2idYknstEx0Ssiki0wn9s8LejQUlurf9H1_3B992KPrPyPp2QoJr_BKCjiWAi6kcUzDO19SN0Q6p6TjDc8c1vsINKDRXD0jJwdffvSHbKqswALgFcOyMzE4n7QBj-YZQrysfKdyA21ZOKGM8zoAVpCpM0HIjrep5bGuA1c8uNw8J1vDYkgvCdV18ipIpXOC4CcIFwFVRC-UN8GHGCvC12K2YaIdx-oXF7aEH52yo2YsaMaiZqypyMf5ksuRc-OuwZ9Rd_NApMsuDWBEdjIie58RVWR7rXk7-fDS1oCEkEpHtRV5O3eD9-GRihvSYgVjhGmR4FHrirwYDWWeSQMzlSDtiugNE9qY6mbPcP6zMHxDUNgANK7Ip7Wx_ZnWHZLYK_Z4v8xsv9_Xx6UVqQSgzbz6H2J8TR7Wo4Mx0W2TreurVXoDmO3a7xT3vAGENTtG priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagXLggEK9AQUbiwENW4yS2415QWVFVSNBDqbQ3y89tpSpbdruV-u-ZSbxZrUDL1XF2R_Owv7En3xDyHnF2gp2VBR9K1rgmMddqy7zA1VAhJMAD_R8_5cl5830qpvnAbZnLKtdrYr9Qh7nHM_KDCvYlJDaRzZfr3wy7RuHtam6hcZ884IBEsHWDmqrNGQuyi4s6X2byVh4sG_hzrMTSDIlZmN7ajnrW_n9Bzb8rJsdr021Q2-9Kx4_Jowwn6dFg_yfkXuyekluwPcXG2HEZaS7LpPNEMwfoFT3teq7qO_phcjY5_XhI199H0tkKaa_wTQpolgI6pGEoxrtcUtsFOham4w_OLHb98NSj6yyekfPjb78mJyz3V2AeUItmyergrYtKQ1yXCRK9JF0rUw1jiVsutXXKA2IQsdWei7ZsYlOGqvKlLL1N9XOy1827-JJQVUUnvZAqRUiBPLcBsEVwXDrtnQ-hIOVazcZn8nHsgXFl-iSklWawjAHLGLSM0QX5NL5yPTBv7Jr8FW03TkTS7H5gvpiZHIOGeyGCEiKBHZtQcqccpJPKliHWziUQcn9teZMjeWk2fleQd-NjiEG8WLFdnK9gDtcN0jwqVZAXg6OMktQgqQBtF0RtudCWqNtPusuLnucbUsMaAHJBPq-dbSPWDk0c9v74f52ZydGkOutHkVAAxvSr3Rp4TR5WQ-gw3u6TvZvFKr4BTHbj3vaB9wcOkjFE priority: 102 providerName: ProQuest – databaseName: Wiley Online Library Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1baxUxEA61vvgiirfVKhF88EJwL7ls-lYXSxG0Qi30LeR6Wih75JwewX_vTHbPlqVSH3zNJmHIzGy-SSbfEPIGcXaCnZUFH0rGHU_MtdoyL_BvqBAS4IH-12_y6JR_ORNnO6TbvoUZ-CGmAzf0jPy_Rge3bqxCku8c1hzmwaQqzZBjhek75C6A-wbNvObfrw9akGI8s1HWEHSxBiD6eLsJ83y8Mctsf8o0_n_DnjdTKKd71DnKzdvU4QNyf8SX9GAwiIdkJ_aPyC8wBoqVsuM60jFPky4THUlBL-lxn8mrf9O33Ul3_G6fbh9M0sUGebBwJAV4SwEu0jBk512sqe0DnTLVccKFxTIgnnq0pdVjcnr4-Ud3xMaCC8wDjNEsWR28dVFpcPQyQeSXpGtlaqAtVbaS2jrlAUKI2GpfibbkkZehrn0pS29T84Ts9ss-PiNU1dFJL6RKERbcVzYA2Aiukk5750MoSLldZuNHNnIsinFpclTSSjNoxoBmDGrG6IK8n4b8HKg4buv8CXU3dUQW7dywXC3M6JSm8kIEJUQCPfJQVk45iC-VLUNsnEsg5N5W82Z07bWpASAhw47kBXk9fQanxJsW28flBvpUmiPvo1IFeToYyiRJA5IKWO2CqJkJzUSdf-kvzjPxN8SKDSDmgnzYGtu1WLesxH62x3-vmekOuvoktyLDALTp5_8z-AW5Vw-Oxap2j-xerTbxJUC4K_cqu-gffhs4Pw priority: 102 providerName: Wiley-Blackwell |
| Title | The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer |
| URI | https://link.springer.com/article/10.1186/s40880-019-0349-9 https://onlinelibrary.wiley.com/doi/abs/10.1186%2Fs40880-019-0349-9 https://www.ncbi.nlm.nih.gov/pubmed/30885279 https://www.proquest.com/docview/2293156464 https://www.proquest.com/docview/2194134977 https://pubmed.ncbi.nlm.nih.gov/PMC6423835 https://doaj.org/article/1c55d755fedc4d01b7b1447a0de3bbfd |
| Volume | 39 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEBZNcumltPTlNl1U6KEPRP3Qw8otMQmh0CQ0DexN6JkEgrdks4X--87YXqemIaUXH2TJHjQz0jfS6BMh7xBnJ5hZWfAhZ9zxxFytLfMCR0OFkAAX9L8eycMz_mUu5gNZNJ6F-XP_vqjl5yWH2pg6pRkyqTC9QbYEjLtozI1sbpdTkEhcVMO-5Z0tJzNPR9B_F6r8Ozly3CGd4tduAjp4TB4NyJHu9qp-Qh7E9in5CWqmeAd2XEY6ZGDSRaID3ecVPW47Wupf9H1z2hx_2KHro5D0fIUMV9iSAnClAARp6PPuLpfUtoGOOej4wXOLF3x46tFKrp-Rs4P9780hG65SYB4AimbJ6uCti0qDC-cJYrokXS1TBWWpsIXU1ikP4EDEWvtC1DmPPA9l6XOZe5uq52SzXbTxJaGqjE56IVWKEO34wgaAEcEV0mnvfAgZydfdbPzAM47XXVyZLt6opek1Y0AzBjVjdEY-jk1-9CQb91XeQ92NFZEfuysAszGDu5nCCxGUEAn0yENeOOUgclQ2D7FyLoGQ22vNm8Fpl6YE6IPcOZJn5O34GtwN91BsGxcrqFNojoyOSmXkRW8ooyQVSCqgtzOiJiY0EXX6pr286Ci9IQqsAAtn5NPa2G7Fuqcndjp7_HefmWa3KU-7UuQOgDL96r9-9Zo8LHtPYkW9TTZvrlfxDaCxGzcjGyU_gaeaqxnZ2ts_Ovk263xz1q1v_AbMay4g |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ZbxMxELZKeYAXBOJaKGAkkDhkdS-v15UQKoEqpddDWylvxmeoVG1K0oD6p_iNzOwVRaDw1Fevd-WdwzPjGX9DyCv0swNYVuasi1lu8sBMKTWzHHdDgS4BHugfHBbD0_zriI_WyO_uLgyWVXZ7Yr1Ru4nFM_LNFOwSApsU-ceLHwy7RmF2tWuh0YjFnr_6BSHb7MPuZ-Dv6zTd-XIyGLK2qwCzYKslC1o6q40XEqQ5DhDehMKURchgLCQ6KaQ2woKd5L6UNuFlnPs8dmlq4yK2OmTw3RvkZo4pRtAfMRKLMx1EM-dZmzxNymJzlsPPYuWXZAgEw-SS-au7BPzLtf27QrNP0y470bUV3LlL7rTuK91u5O0eWfPVffITZI1iI24_87QtA6WTQFvM0XN6VNXY2Ff0zeB4cPR2i3b3Mel4jjBb-CYF75mCN0pdU_x3NqO6crQvhMcPjjV2GbHUoqhOH5DTa6H8Q7JeTSr_mFCRelNYXojgIeSyiXbgyziTFEZaY52LSNyRWdkW7Bx7bpyrOugpC9VwRgFnFHJGyYi861-5aJA-Vk3-hLzrJyJIdz0wmY5Vq_MqsZw7wXkAPuYuTowwEL4KHTufGRNgkRsd51W7c8zUQs4j8rJ_DDqPiRxd-ckc5iQyR1hJISLyqBGUfiUZrJQDtSMilkRoaanLT6qz7zWuOISiGTjkEXnfCdtiWSsosVXL4_9ppgbbg_S4HkUAAxiTT1ZT4AW5NTw52Ff7u4d7T8nttFEjlpQbZP1yOvfPwB-8NM9rJaTk23Vr_R85_m6T |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1baxUxEA5aQXwRxdtq1Qg-eCF0b0k2faurh3prhVroW8j1tFD2lHMR_PfO7K0sloqv2WR3yMxsvkkm3xDyGnF2hJWVeedTVtoyMlspwxzHv6FESIAb-t8PxP5x-eWEn_R1TldDtvtwJNndaUCWpma9c-Fj5-KV2FmV8A5MqFIM-VWYukluIVUX5vTVor7cZEF6cV70p5lXjpysRy1t_1VY8--UyfHcdIpq22Vpdo_c7fEk3esM4D65EZoH5Bcon2Jl7LAKtM_LpItIexLQc3rYtGTVv-mb-qg-fLtLhwuSdL5B3iscSQHOUoCH1HfZeGcrahpPx8x0fOHcYNkPRx3azvIhOZ59-lnvs77AAnMAWxSLRnlnbJAKHDuNEOlFYSsRC2iLmcmEMlY6gAw8VMplvErLUKY-z10qUmdi8YhsNYsmPCFU5sEKx4WMAWIglxkP4MLbTFjlrPM-Iekwzdr17ONYBONct1FIJXSnGQ2a0agZrRLybhxy0VFvXNf5A-pu7Iis2W3DYjnXvRPqzHHuJecR9Fj6NLPSQjwpTepDYW0EIbcHzevelVc6B0CEjDqiTMir8TE4IZ6smCYsNtAnUyXyPEqZkMedoYySFCAph9lOiJyY0ETU6ZPm7LQl-obYsACEnJD3g7FdinXNTOy29vjvOdP1Xp0fta3IKABt6ul_feoluf3j40x_-3zw9Rm5k3dOxbJqm2ytl5vwHODa2r5oXfIPkm81Eg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Chinese+Society+of+Clinical+Oncology+%28CSCO%29%3A+clinical+guidelines+for+the+diagnosis+and+treatment+of+gastric+cancer&rft.jtitle=Cancer+communications+%28London%2C+England%29&rft.au=Wang%2C+Feng-Hua&rft.au=Shen%2C+Lin&rft.au=Li%2C+Jin&rft.au=Zhou%2C+Zhi-Wei&rft.date=2019-03-18&rft.pub=BioMed+Central&rft.eissn=2523-3548&rft.volume=39&rft.issue=1&rft_id=info:doi/10.1186%2Fs40880-019-0349-9&rft.externalDocID=10_1186_s40880_019_0349_9 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2523-3548&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2523-3548&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2523-3548&client=summon |